Nyxoah SA (NYXH)Healthcare | Medical Instruments & Supplies | Mont-Saint-Guibert, Belgium | NasdaqGM
3.22 USD
-0.01
(-0.310%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 3.23 +0.01 (0.311%) ⇧ (April 21, 2026, 4:10 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:33 p.m. EDT
Despite recent volatility and a lack of fundamental consensus due to losses, thebearish neutral momentum (1.0/5 short-term) for NYXH is underscored by a strong statistical forecast model predicting a 5.9% downside over the next 45 days, primarily driven by confirmed Q4 revenue misses and a specific Baird analyst price target reduction to $4.62, signaling immediate pressure for near-term momentum cleaning. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.229494 |
| MSTL | 0.232740 |
| AutoETS | 0.243906 |
| AutoARIMA | 0.264756 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 82.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.111 |
| Excess Kurtosis | -1.51 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 85.644 |
| Revenue per Share | 0.263 |
| Market Cap | 140,592,944 |
| Forward P/E | -1.99 |
| Beta | 0.87 |
| Previous Name | Nyxoah S.A. |
| Website | https://www.nyxoah.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.4661157 |
| Address1 | Rue Edouard Belin 12 |
| All Time High | 37.0 |
| All Time Low | 2.76 |
| Ask | 3.33 |
| Ask Size | 1 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 40,420 |
| Average Daily Volume3 Month | 55,759 |
| Average Volume | 55,759 |
| Average Volume10Days | 40,420 |
| Beta | 0.874 |
| Bid | 3.2 |
| Bid Size | 1 |
| Book Value | 1.3405824 |
| City | Mont-Saint-Guibert |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Belgium |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.22 |
| Current Ratio | 1.25 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.3872 |
| Day Low | 3.2 |
| Debt To Equity | 85.644 |
| Display Name | Nyxoah |
| Earnings Call Timestamp End | 1,773,952,200 |
| Earnings Call Timestamp Start | 1,773,952,200 |
| Earnings Timestamp | 1,778,616,000 |
| Earnings Timestamp End | 1,778,616,000 |
| Earnings Timestamp Start | 1,778,616,000 |
| Ebitda | -82,354,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.641 |
| Enterprise To Revenue | 13.483 |
| Enterprise Value | 135,104,560 |
| Eps Current Year | -1.7552 |
| Eps Forward | -1.6209073 |
| Eps Trailing Twelve Months | -2.78 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 32 1 045 90 75 |
| Fifty Day Average | 3.65392 |
| Fifty Day Average Change | -0.4339199 |
| Fifty Day Average Change Percent | -0.11875463 |
| Fifty Two Week Change Percent | -46.611572 |
| Fifty Two Week High | 8.64 |
| Fifty Two Week High Change | -5.42 |
| Fifty Two Week High Change Percent | -0.6273148 |
| Fifty Two Week Low | 2.76 |
| Fifty Two Week Low Change | 0.46000004 |
| Fifty Two Week Low Change Percent | 0.16666669 |
| Fifty Two Week Range | 2.76 - 8.64 |
| Financial Currency | EUR |
| First Trade Date Milliseconds | 1,619,616,600,000 |
| Float Shares | 24,490,678 |
| Forward Eps | -1.6209073 |
| Forward P E | -1.9865417 |
| Free Cashflow | -43,225,376 |
| Full Exchange Name | NasdaqGM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.63133997 |
| Gross Profits | 6,326,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.37035 |
| Held Percent Institutions | 0.21181 |
| Implied Shares Outstanding | 43,662,403 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,021-07-02 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. |
| Long Name | Nyxoah SA |
| Market | us_market |
| Market Cap | 140,592,944 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_264235912 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -90,085,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 143,769,804 |
| Number Of Analyst Opinions | 4 |
| Open | 3.365 |
| Operating Cashflow | -68,979,000 |
| Operating Margins | -3.29288 |
| Payout Ratio | 0.0 |
| Phone | 32 1 022 23 55 |
| Post Market Change | 0.00999999 |
| Post Market Change Percent | 0.3105587 |
| Post Market Price | 3.23 |
| Post Market Time | 1,776,802,205 |
| Prev Name | Nyxoah S.A. |
| Previous Close | 3.23 |
| Price Eps Current Year | -1.8345487 |
| Price Hint | 4 |
| Price To Book | 2.4019413 |
| Price To Sales Trailing12 Months | 14.031232 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.135 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.6 |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.30959722 |
| Regular Market Day High | 3.3872 |
| Regular Market Day Low | 3.2 |
| Regular Market Day Range | 3.2 - 3.3872 |
| Regular Market Open | 3.365 |
| Regular Market Previous Close | 3.23 |
| Regular Market Price | 3.22 |
| Regular Market Time | 1,776,801,600 |
| Regular Market Volume | 13,350 |
| Return On Assets | -0.37671003 |
| Return On Equity | -1.10954 |
| Revenue Growth | 3.469 |
| Revenue Per Share | 0.263 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 43,662,403 |
| Shares Percent Shares Out | 0.0070999996 |
| Shares Short | 308,245 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 269,125 |
| Short Name | Nyxoah SA |
| Short Percent Of Float | 0.0097 |
| Short Ratio | 5.33 |
| Source Interval | 15 |
| Symbol | NYXH |
| Target High Price | 13.199483 |
| Target Low Price | 8.028648 |
| Target Mean Price | 10.33345 |
| Target Median Price | 10.052835 |
| Total Cash | 48,001,000 |
| Total Cash Per Share | 1.099 |
| Total Debt | 42,076,000 |
| Total Revenue | 10,020,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.78 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.161365 |
| Two Hundred Day Average Change | -1.941365 |
| Two Hundred Day Average Change Percent | -0.37613404 |
| Type Disp | Equity |
| Volume | 13,350 |
| Website | https://www.nyxoah.com |
| Zip | 1,435 |